AFIA
GILD icon

America First Investment Advisors’s Gilead Sciences GILD Stock Holding History

America First Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200
Closed -$14K – 120
2017
Q1 		$14K Buy
+200
New +$14.1K 0.01% 115
2016
Q4 		– Sell
-57
Closed -$5K – 117
2016
Q3 		$5K Buy
+57
New +$4.63K ﹤0.01% 97

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

America First Investment Advisors's GILD Position: Q2 2017 in Review

America First Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 200 shares — an estimated $14K sold.

America First Investment Advisors first reported a position in GILD in Q3 2016 and held it in 2 quarters. The position peaked at $14K in Q1 2017. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • America First Investment Advisors reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • America First Investment Advisors sold 200 Gilead Sciences shares in Q2 2017, an estimated $14K.
  • America First Investment Advisors first reported a position in Gilead Sciences in Q3 2016 and held it in 2 quarters.
  • America First Investment Advisors's Gilead Sciences position peaked at $14K in Q1 2017.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on America First Investment Advisors's 13F filing for Q2 2017, filed 10 Jul 2017.